Judo Bio
Oligonucleotide therapeutics designed for kidney delivery
- Sector
- Biotech
- Headquarters
- CAMBRIDGE, MA
- Founded
- 2021
- Latest Form D
- $25M, Aug 2024
- Total capital
- $50M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $50M
- 3 Form D · last Aug 2024
- 26 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 13 pending
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 3rd filing$25M
- Private capital raisedForm D · SEC · 2nd filing$5M
- Private capital raisedForm D · SEC · 1st filing$20M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Founders and team
From SEC Form D filings- ANKIT JEFFREY MAHADEVIADirectorNamed in SEC Form D filings
- CHELSEA PLACE JOHNSONDirectorNamed in SEC Form D filings
- GEORGE JEFFREY GOLUMBESKIDirectorNamed in SEC Form D filings
- HUI JEFFREY TIANDirectorNamed in SEC Form D filings
- JAMES JEFFREY GOATERExecutive Officer, DirectorNamed in SEC Form D filings
- KEVIN BITTERMANExecutive Officer, DirectorNamed in SEC Form D filings
Show all 9 people
- OMMER CHOHANExecutive OfficerNamed in SEC Form D filings
- ROBERT GAFFEYExecutive OfficerNamed in SEC Form D filings
- SAM JEFFREY BJORKDirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 13- PendingTargeted DeliveryUSPTOApplication 18850312
- PendingSLC6A19-TARGETING Modulatory Nucleic Acid AgentsUSPTOApplication PCTUS2024048852
- PendingAminoglycosides For Delivery Of Agents To The KidneyUSPTOApplication PCTUS2024048893
Show all 13 patent records
- Targeted DeliveryJul 3, 2025 · Application 18850312Pending
- SLC6A19-TARGETING Modulatory Nucleic Acid AgentsApplication PCTUS2024048852Pending
- Aminoglycosides For Delivery Of Agents To The KidneyApplication PCTUS2024048893Pending
- SLC6A19-TARGETING Modulatory Nucleic Acid AgentsApplication 63655344Pending
- Polymyxins For Delivery Of Agents To The KidneyApplication 63655321Pending
- Aminoglycosides For Delivery Of Agents To The KidneyApplication 63655325Pending
- SLC6A19-TARGETING Modulatory Nucleic Acid AgentsApplication 63585781Pending
- Polymyxins For Delivery Of Agents To The KidneyApplication 63585806Pending
- Aminoglycosides For Delivery Of Agents To The KidneyApplication 63585794Pending
- Targeted DeliveryApplication PCTUS2023016319Pending
- Megalin Targeting Moieties And Uses ThereofApplication 63323635Pending
- Polymyxins For Delivery Of Agents To The KidneyApplication PCTUS2024048913Pending
- Targeted DeliveryApplication 63323633Pending
Related companies, and why
- Dyne TherapeuticsSimilar federal contract value in Biotech · null in contracts
- Kailera TherapeuticsSimilar federal contract value in Biotech · null in contracts
- Intellia TherapeuticsSimilar federal contract value in Biotech · null in contracts
- Kinaset TherapeuticsSimilar federal contract value in Biotech · null in contracts
- Korro BioSimilar federal contract value in Biotech · null in contracts
- Altis LabsSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .